Scilex Company (SCLX) Revenue & Revenue Breakdown
Scilex Company Revenue Highlights
Latest Revenue (Y)
$46.74M
Latest Revenue (Q)
$16.37M
Scilex Company Revenue by Period
Scilex Company Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $46.74M | 22.90% |
| 2022-12-31 | $38.03M | 21.45% |
| 2021-12-31 | $31.32M | 32.92% |
| 2020-12-31 | $23.56M | 12.01% |
| 2019-12-31 | $21.03M | - |
Scilex Company generated $46.74M in revenue during NA 2023, up 22.90% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Scilex Company Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $16.37M | 50.40% |
| 2024-03-31 | $10.88M | -19.15% |
| 2023-12-31 | $13.46M | 33.06% |
| 2023-09-30 | $10.12M | -19.59% |
| 2023-06-30 | $12.58M | 18.90% |
| 2023-03-31 | $10.58M | -11.22% |
| 2022-12-31 | $11.92M | 4.76% |
| 2022-09-30 | $11.38M | 43.54% |
| 2022-06-30 | $7.93M | 16.35% |
| 2022-03-31 | $6.81M | -17.56% |
| 2021-12-31 | $8.26M | -0.71% |
| 2021-09-30 | $8.32M | 6.29% |
| 2021-06-30 | $7.83M | - |
| 2021-03-31 | $7.83M | 32.92% |
| 2020-12-31 | $5.89M | - |
| 2020-09-30 | $5.89M | - |
| 2020-06-30 | $5.89M | - |
| 2020-03-31 | $5.89M | 12.01% |
| 2019-12-31 | $5.26M | - |
| 2019-09-30 | $5.26M | - |
| 2019-06-30 | $5.26M | - |
| 2019-03-31 | $5.26M | - |
Scilex Company generated $16.37M in revenue during Q2 2024, up 50.40% compared to the previous quarter, and up 154.70% compared to the same period a year ago.
Scilex Company Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MRK | Merck | $60.12B | $16.11B |
| ABBV | AbbVie | $54.32B | $14.46B |
| NVS | Novartis | $46.66B | $11.83B |
| AZN | AstraZeneca | $45.81B | $12.68B |
| BMY | Bristol-Myers Squibb Company | $45.01B | $11.89B |
| SNY | Sanofi | $43.07B | $11.12B |
| LLY | Eli Lilly and Company | $34.12B | $11.44B |
| GSK | GSK | $30.33B | $7.36B |
| AMGN | Amgen | $28.19B | $8.50B |
| GILD | Gilead Sciences | $27.12B | $6.95B |
| BIIB | Biogen | $9.84B | $2.47B |
| SCLX | Scilex Company | $46.74M | $16.37M |
SCLX Revenue FAQ
What is Scilex Company’s yearly revenue?
Scilex Company's yearly revenue for 2023 was $46.74M, representing an increase of 22.90% compared to 2022. The company's yearly revenue for 2022 was $38.03M, representing an increase of 21.45% compared to 2021. SCLX's yearly revenue for 2021 was $31.32M, representing an increase of 32.92% compared to 2020.
What is Scilex Company’s quarterly revenue?
Scilex Company's quarterly revenue for Q2 2024 was $16.37M, a 50.40% increase from the previous quarter (Q1 2024), and a 30.11% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $10.88M, a -19.15% decrease from the previous quarter (Q4 2023), and a 2.85% increase year-over-year (Q1 2023). SCLX's quarterly revenue for Q4 2023 was $13.46M, a 33.06% increase from the previous quarter (Q3 2023), and a 12.95% increase year-over-year (Q4 2022).
What is Scilex Company’s revenue growth rate?
Scilex Company's revenue growth rate for the last 3 years (2021-2023) was 49.26%, and for the last 5 years (2019-2023) was 122.24%.